ATE260293T1 - 3'-n-modifizierte 6-0 substituierte erythromycin ketolide derivate mit antibakterieller wirkung - Google Patents

3'-n-modifizierte 6-0 substituierte erythromycin ketolide derivate mit antibakterieller wirkung

Info

Publication number
ATE260293T1
ATE260293T1 AT98946087T AT98946087T ATE260293T1 AT E260293 T1 ATE260293 T1 AT E260293T1 AT 98946087 T AT98946087 T AT 98946087T AT 98946087 T AT98946087 T AT 98946087T AT E260293 T1 ATE260293 T1 AT E260293T1
Authority
AT
Austria
Prior art keywords
modified
antibacterial action
substituted erythromycin
ketolide derivatives
erythromycin ketolide
Prior art date
Application number
AT98946087T
Other languages
English (en)
Inventor
Yat Sun Or
Zhenkun Ma
Daniel T Chu
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Application granted granted Critical
Publication of ATE260293T1 publication Critical patent/ATE260293T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
AT98946087T 1997-09-30 1998-09-16 3'-n-modifizierte 6-0 substituierte erythromycin ketolide derivate mit antibakterieller wirkung ATE260293T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US94087197A 1997-09-30 1997-09-30
US13312198A 1998-08-12 1998-08-12
PCT/US1998/019311 WO1999016779A1 (en) 1997-09-30 1998-09-16 3'-n-modified 6-o-substituted erythromycin ketolide derivatives having antibacterial activity

Publications (1)

Publication Number Publication Date
ATE260293T1 true ATE260293T1 (de) 2004-03-15

Family

ID=26831064

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98946087T ATE260293T1 (de) 1997-09-30 1998-09-16 3'-n-modifizierte 6-0 substituierte erythromycin ketolide derivate mit antibakterieller wirkung

Country Status (22)

Country Link
EP (1) EP1025114B1 (de)
JP (1) JP2001518476A (de)
KR (1) KR20010030807A (de)
CN (1) CN1271363A (de)
AR (1) AR015727A1 (de)
AT (1) ATE260293T1 (de)
AU (1) AU737310B2 (de)
BG (1) BG104340A (de)
BR (1) BR9812577A (de)
CA (1) CA2303930A1 (de)
CO (1) CO4990958A1 (de)
DE (1) DE69821964T2 (de)
DK (1) DK1025114T3 (de)
ES (1) ES2217579T3 (de)
HU (1) HUP0004579A3 (de)
IL (1) IL134608A0 (de)
NO (1) NO20001439L (de)
PL (1) PL339575A1 (de)
PT (1) PT1025114E (de)
SK (1) SK4562000A3 (de)
TR (1) TR200000805T2 (de)
WO (1) WO1999016779A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4573925B2 (ja) * 1998-07-09 2010-11-04 アベンティス・ファーマ・ソシエテ・アノニム 新規のエリスロマイシン誘導体、その製造方法及びその薬剤としての使用
AU775637B2 (en) * 1999-04-16 2004-08-12 Kosan Biosciences, Inc. Macrolide antiinfective agents
US6355620B1 (en) * 1999-05-14 2002-03-12 Abbott Laboratories C-2 modified erythromycin derivatives
US6437106B1 (en) 1999-06-24 2002-08-20 Abbott Laboratories Process for preparing 6-o-substituted erythromycin derivatives
AU2001277764A1 (en) * 2000-08-14 2002-02-25 Taisho Pharmaceutical Co., Ltd. Process for producing erythromycin derivative
US20020128213A1 (en) * 2000-09-25 2002-09-12 Leonard Katz Sixteen-membered macrolide compounds
ITMI20021726A1 (it) 2002-08-01 2004-02-02 Zambon Spa Macrolidi ad attivita' antiinfiammatoria.
US7091196B2 (en) 2002-09-26 2006-08-15 Rib-X Pharmaceuticals, Inc. Bifunctional heterocyclic compounds and methods of making and using same
CN1950388A (zh) * 2004-02-27 2007-04-18 瑞伯-X医药品有限公司 大环化合物以及其制作和使用方法
EP2716647A3 (de) * 2004-02-27 2014-08-20 Rib-X Pharmaceuticals, Inc. Makrocyclische Verbindungen Und Verfahren Zu Deren Herstellung Und Anwendung
WO2006080954A1 (en) * 2004-07-28 2006-08-03 Ranbaxy Laboratories Limited Ketolide derivatives as antibacterial agents
WO2006046112A2 (en) * 2004-10-25 2006-05-04 Ranbaxy Laboratories Limited Ketolide derivatives as antibacterial agents
WO2006129257A2 (en) * 2005-05-30 2006-12-07 Ranbaxy Laboratories Limited Ketolide derivatives as antibacterial agents
EP1934237A2 (de) 2005-08-24 2008-06-25 Rib-X Pharmaceuticals, Inc. Triazolverbindungen und verfahren zu deren herstellung und anwendung
EP1928893A2 (de) 2005-08-24 2008-06-11 Rib-X Pharmaceuticals, Inc. Triazolverbindungen und verfahren zu ihrer herstellung und verwendung
WO2007060518A2 (en) * 2005-11-23 2007-05-31 Ranbaxy Laboratories Limited Ketolide derivatives as antibacterial agents
JP5126685B2 (ja) * 2006-05-01 2013-01-23 大正製薬株式会社 マクロライド誘導体
WO2008099368A1 (en) * 2007-02-15 2008-08-21 Ranbaxy Laboratories Limited Macrolide derivatives as antibacterial agents
WO2008111020A2 (en) * 2007-03-14 2008-09-18 Ranbaxy Laboratories Limited Macrolide derivatives as antibacterial agents

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL99995A (en) * 1990-11-21 1997-11-20 Roussel Uclaf Erythromycin derivatives, their preparation and pharmaceutical compositions containing them
PT876388E (pt) * 1995-11-08 2004-07-30 Abbott Lab Derivados de eritromicina triciclica

Also Published As

Publication number Publication date
AR015727A1 (es) 2001-05-16
IL134608A0 (en) 2001-04-30
ES2217579T3 (es) 2004-11-01
KR20010030807A (ko) 2001-04-16
DK1025114T3 (da) 2004-07-05
CA2303930A1 (en) 1999-04-08
DE69821964D1 (de) 2004-04-01
NO20001439D0 (no) 2000-03-20
CN1271363A (zh) 2000-10-25
HUP0004579A3 (en) 2001-11-28
BR9812577A (pt) 2000-10-17
SK4562000A3 (en) 2000-09-12
NO20001439L (no) 2000-05-29
DE69821964T2 (de) 2004-12-30
EP1025114A1 (de) 2000-08-09
BG104340A (en) 2001-01-31
PL339575A1 (en) 2000-12-18
PT1025114E (pt) 2004-07-30
HUP0004579A2 (hu) 2001-05-28
AU737310B2 (en) 2001-08-16
WO1999016779A1 (en) 1999-04-08
JP2001518476A (ja) 2001-10-16
TR200000805T2 (tr) 2000-10-23
AU9317698A (en) 1999-04-23
EP1025114B1 (de) 2004-02-25
CO4990958A1 (es) 2000-12-26

Similar Documents

Publication Publication Date Title
DE69821964D1 (de) 3'-n-modifizierte 6-0 substituierte erythromycin ketolide derivate mit antibakterieller wirkung
ATE234817T1 (de) Hetaroylcyclohexandionderivate mit herbizider wirkung
FI971516A7 (fi) Antimikrobinen koostumus
DE69621472D1 (de) Antimikrobielle Polymer-Zusammensetzung
DE69919156D1 (de) Oxyiminoalkansäure derivate mit hypoglykämischer und hypolipidemischer wirkung
DE69832486D1 (de) C-4"-substitutierte macrolid-derivate
BR9711970A (pt) Derivados 6,5-substitu¡do-heterobic¡clicos
EP1005356A4 (de) Neuartige antibiotika
DE69934805D1 (de) Substituierte imidazole mit cytokin-inhibierender wirkung
ATE252108T1 (de) 3'-n-oxid,3'-n-dimethylamin,9-oxime erythromycin a derivate
ATE275151T1 (de) 3,6-ketal-makrolidantibiotika
DE69908338D1 (de) 15-gliedrige ketolid-lactame mit antibakterieller wirkung
BR9307347A (pt) Derivados de 5-hidrazino-quinolina antimicrobianos
DE69927008D1 (de) Verbindungen mit kalzilytischer wirkung
ATE257484T1 (de) 6,9-verbrückte erythromycin-derivate
ATE298760T1 (de) 2-halo-6-0-substituierte ketolide derivate
ATE239750T1 (de) 6,11-verbrückte erythromycinderivate
ATE315042T1 (de) 9a-azalide mit antibakterieller wirkung
DE69621471D1 (de) Kristalline antimikrobielle Zusammensetzung
PT1060183E (pt) Derivados de 5'-desoxicitidina
ATE240297T1 (de) Substituierte phenylamidine mit antithrombotischer wirkung
NO965109D0 (no) Antimikrobielle sammensetninger
DK1077984T3 (da) 2'-Deoxyhygromycin derivater
DE69611272D1 (de) Pestizide Zusammensetzungen mit Diarylalkanen
DE19781792T1 (de) 6,7-Dihydroxy-8-methyl-4-oxo-4H-1-benzopyran-5-carbonsäure mit antibakterieller Wirkung

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1025114

Country of ref document: EP

REN Ceased due to non-payment of the annual fee